Review
Copyright ©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 304-318
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.304
Table 1 Summary of existing rodent models of non-alcoholic fatty liver disease
Rodent models
Obesity
Insulin resistance
Steatosis
NASH
Fibrosis
HCC
Dietary
Deficient diet
MCDNoHepatic IRYesYesYesNo
CDAANoNoYesYesYesYes
High-amount diet
HFDYesYesYesYesYesNo
HFHSYesYesYesYesYesNo
High fructose dietNoYesYesNoNoNo
HFHCYesYesYesYesYesNo
Atherogenic diet (cholesterol + cholate)NoHepatic IRYesYesYesNo
Cafeteria diet or Western dietYesYesYesYesNo-
ALIOSYesYesYesYesYesYes
AMLNYesYesYesYesYesNo
DIAMONDYesYesYesYesYesYes
Genetic
ob/obYesYesYesNoNoNo
db/dbYesYesYesNoNoNo
KK-AyYesYesYesNoNoNo
foz/fozYesYesYesNoNoNo
fa/faYesYesYesNoNoNo
PTEN knockoutNoNoYesYesYesYes
PPAR-α knockoutNoNoYesNoNoNo
SREBP-1c transgenicNoYesYesNoNoNo
Chemicals
TetracyclineNoNoYesYesYes-
CCl4NoNoYesYesYesYes
TAA--YesYesYesYes
STZ---Yes--
DMN--NoYesYesYes
DENNo-YesYesYesYes
Porphyrinogenic agents (DDC or GF)--YesYes--
MSGYesYesYesYesNoYes
Tunicamycin--YesYes--
Surgical
CBDL--YesYesYes-
Combined models
ob/ob + MCD dietYes-YesYesNoNo
db/db + MCD dietYesYesYesYesYesNo
HFD + thermoneutral housing at 30 ºC---YesYes-
HFD + CCl4No-YesYesYesYes
HFD + DENYes-YesYesYesYes
CDAA + CCl4No-YesYesYesYes
STAM modelNo-YesYesYesYes